Cases 11 - 20 of 55
AbbVie Inc. v. Hetero Labs Limited et al
as 1:2024cv00151
Plaintiff:
AbbVie Inc.
Defendant:
Hetero Labs Limited, Hetero Labs Limited Unit-V and Hetero USA Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AXSOME MALTA LTD. et al v. HETERO USA INC. et al
as 2:2024cv00196
Plaintiff:
AXSOME MALTA LTD. and AXSOME THERAPEUTICS, INC.
Defendant:
HETERO USA INC., HETERO LABS LIMITED UNIT-V and HETERO LABS LTD.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AbbVie Inc. v. Hetero USA, Inc. et al
as 1:2023cv01332
Plaintiff:
AbbVie Inc.
Defendant:
Hetero USA, Inc., Hetero Labs Limited, Hetero Labs Limited Unit-V and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AXSOME MALTA LTD. et al v. ALKEM LABORATORIES LTD. et al
as 2:2023cv20354
Plaintiff:
AXSOME MALTA LTD. and AXSOME THERAPEUTICS, INC.
Defendant:
ALKEM LABORATORIES LTD., AUROBINDO PHARMA USA, INC., HETERO USA INC. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AbbVie Inc. v. Hetero Labs Limited et al
as 1:2023cv00448
Plaintiff:
AbbVie Inc.
Defendant:
Hetero Labs Limited, Hetero Labs Limited Unit-V and Hetero USA Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AbbVie Inc. et al v. Alkem Laboratories Limited et al
as 1:2022cv01423
Plaintiff:
AbbVie Inc., AbbVie Ltd. and Neurocrine Biosciences, Inc.
Defendant:
Alkem Laboratories Limited, Hetero Labs Limited, Hetero Labs Limited Unit-V and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Hetero USA Inc. et al
as 1:2023cv00048
Plaintiff:
Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, Boehringer Ingelheim Corporation and others
Defendant:
Hetero USA Inc., Hetero Labs Limited Unit-V and Hetero Labs Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
MERCK SHARP & DOHME LLC v. HETERO USA, INC. et al
as 2:2022cv06820
Plaintiff:
MERCK SHARP & DOHME LLC
Defendant:
HETERO USA, INC., HETERO LABS LIMITED UNIT-V and HETERO LABS LIMITED
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
ARAGON PHARMACEUTICALS, INC. et al v. HETERO LABS LIMITED UNIT V et al
as 2:2022cv03212
Plaintiff:
ARAGON PHARMACEUTICALS, INC., JANSSEN BIOTECH, INC., THE REGENTS OF THE UNIVERSITY OF CALIFORNIA and others
Defendant:
HETERO LABS LIMITED UNIT V and HETERO USA, INC.
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
Aragon Pharmaceuticals, Inc. et al v. Hetero Labs Limited Unit V et al
as 1:2022cv00696
Plaintiff:
Aragon Pharmaceuticals, Inc., Janssen Biotech, Inc., The Regents of the University of California and others
Defendant:
Hetero Labs Limited Unit V and Hetero USA, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
